You searched for "fovea"
East Bound and Down: Patrick Staropoli
2 August 2024
| Peter Cackett
|
EYE - General
One of my heroes growing up in the 70s was the iconic Formula 1 racing driver, James Hunt. At the time, if you had asked me and my primary school friends what we would most like to do for a...
An interview with Professor John Forrester
2 December 2019
| Hari Kaneshayogan
|
EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...
In conversation with John Forrester
2 December 2019
| Hari Kaneshayogan
|
EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...
Twenty-five years in retina
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...Moorfields: The 2025 macula course
2 June 2025
-5 June 2025
The 2025 Macula course will take place from 2nd - 5th June 2025. Bookings are now open. Retinal diseases are a major cause of blindness. Diagnostic investigations, understanding of disease mechanisms, new therapies, and the evidence base, have all evolved...
Endoscopic Surgery of the Orbit: Anatomy, Pathology, and Management
3 June 2021
| Teresa Lupión Durán
Endoscopic surgery still remains a challenge for many oculoplastic surgeons, whose main scope of work has traditionally been open surgery. The learning curve for endoscopic surgery is quite steep and this approach requires skills that needs to be well trained,...
Quarter DMEK
This case report describes a novel technique where one quarter of Descemet’s membrane (DM) was transplanted during a quarter-descemet membrane endothelial keratoplasty (DMEK) procedure. DMEK graft was prepared from a 58-year-old corneo-scleral donor after one week in culture. Peripheral DM...
Ovarian hormones drive onset of Sjogren’s disease in mice
1 December 2014
| Graham Wallace
|
EYE - Cornea, EYE - General
|
Sjögren’s Syndrome, lacrimal glands, sex hormones, cytokines, anti-Ro/SSA, anti-La/SSB, NOD.B10.H2b
Sjogren’s syndrome (SS) is a debilitating, sight-threatening, systemic autoimmune disease with no effective treatment available. SS is characterised by lacrimal gland lymphocytic infiltration and epithelial cell death, as well as by the presence of serum autoantibodies. Patients have severe dry...
Transcriptomic analysis of ocular tissues
1 August 2018
| Graham Wallace
|
EYE - Glaucoma
Transcriptomics is defined as the analysis of the complete set of RNA transcripts present in a cell under different circumstances, quiescent versus challenge, by microarray analysis. Comparison of transcriptomes identifies genes that are differentially expressed in different cell populations under...
CD40L activation of human RPE cells
1 August 2018
| Graham Wallace
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of reduced visual acuity in the elderly worldwide. The risk factors involved in AMD include smoking and diet, while genetics have been shown to have a significant role. Recently a link between...
Multimodal imaging in wet AMD
1 April 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
This novel study set out to determine grader agreement levels of various retinal imaging techniques, commonly used in the diagnosis of wet age-related macular degeneration (AMD). Images from 52 eyes were by examined by two different observers. All images were...
Results of four years of implantation of XEN glaucoma gel stent
2 December 2019
| Ivan Yip
|
EYE - Glaucoma
|
MIGS, XEN glaucoma gel microstent, efficacy, long-term, safety
This multi-centred prospective, non-randomised study presents the long-term clinical outcomes in patients after implantation of transscleral XEN Glaucoma Gel Microstent, 63μm. (XEN-GGM, Allergan, New Jersey). It was conducted in Austria, Canada and Germany. Sixty-four consecutive eyes of 64 patients with...
